Clinical Trials Logo
  1. Home
  2. Communicable Diseases
  3. NCT00001477

Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

Communicable Diseases Clinical Trial

Official title:
Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy

Clinical Trial Summary

Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i.e. PPD), or immunologic parameters. A quantitative and specific method that is non-invasive, such as quantitative PCR, would be desirable to more precisely define those who would benefit from prophylaxis. Similarly, when patients develop disease and are being treated, quantitative, non-invasive techniques are needed to assess response to therapy. This project is designed to develop and test quantitative tests using blood, urine, or sputum samples.

Clinical Trial Description

Patients are exposed to infectious agents regularly, regardless of their immunologic status. Traditionally clinicians have decided to institute prophylaxis based on epidemiologic factors, skin test (i.e. PPD), or immunologic parameters. A quantitative and specific method that is non-invasive, such as quantitative PCR, would be desirable to more precisely define those who would benefit from prophylaxis. Similarly, when patients develop disease and are being treated, quantitative, non-invasive techniques are needed to assess response to therapy. This project is designed to develop and test quantitative tests using blood, urine, or sputum samples. ;

Study Design

N/A

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00001477
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase N/A
Start date August 1995
Completion date October 2000
View Details
See also
  Status Clinical Trial Phase
Completed NCT03120975 - Computerized Antibiotic Stewardship Study N/A
Recruiting NCT06112249 - SAFE Workplace Intervention for People With IDD N/A
Recruiting NCT05394363 - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed NCT01232686 - Snow Disease Surveillance System Study N/A
Completed NCT06133400 - Mapping the Health Status of the Population of French Polynesia: the MATAEA Project N/A
Enrolling by invitation NCT02338986 - Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Completed NCT02740140 - Epidemiology of H. Pylori Transmission N/A
Recruiting NCT06164600 - Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children Phase 2
Completed NCT03931941 - Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) Phase 3
Completed NCT02434848 - A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses Phase 2/Phase 3
Completed NCT02606981 - Automatic Chlorination and Child Health in Urban Bangladesh N/A
Completed NCT02046512 - Probiotics to Promote Intestinal Health Phase 4
Completed NCT00140335 - Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools Phase 4
Completed NCT01873040 - Vaccine Social Media Randomized Intervention Trial N/A
Enrolling by invitation NCT02422875 - Comparative Autoantibody and Immunologic Cell Marker Study
Completed NCT02665013 - Reducing Delay of Vaccination in Children Study N/A
Completed NCT04603313 - Opinion of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics
Active, not recruiting NCT03894566 - NASCITA Italian Birth Cohort Study
Withdrawn NCT00006630 - Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection Phase 1